Key result
Prior CABG linked to ~103% higher mortality risk in invasively managed ACS patients.
Why the study?
Coronary angiography in patients with previous CABG is technically more difficult with increased procedure time, radiation exposure, and in-hospital complications, prompting comparison of management and outcomes in contemporary practice.
Does prior CABG worsen clinical outcomes in ACS patients undergoing an invasive strategy compared to those without prior CABG?
Cohort (n=26,869)
Yes
Does prior CABG worsen clinical outcomes in ACS patients undergoing an invasive strategy compared to those without prior CABG?
In contemporary practice, ACS patients with prior CABG undergoing an invasive strategy have significantly worse clinical outcomes and lower revascularisation rates compared to those without prior CABG.
Answers are grounded in this paper and cite their sources.
Prior CABG was associated with higher ACS mortality; leaves open whether targeted strategies improve outcomes in this subgroup.
AIMS: Coronary angiography in patients with previous coronary artery bypass grafts (CABG) is technically more difficult with increased procedure time, radiation exposure and in-hospital complications. In a contemporary national registry of acute coronary syndrome (ACS) patients undergoing an invasive strategy, we compared the management and outcomes of patients with and without prior CABG. METHODS: The All New Zealand ACS Quality Improvement (ANZACS-QI) registry was used to identify patients admitted to New Zealand public hospitals with an ACS who underwent invasive coronary angiography (2014-2018). Outcomes were ascertained by anonymised linkage to national datasets. RESULTS: Of 26,869 patients, 1,791 (6.7%) had prior CABG and 25,078 (93.3%) had no prior CABG. Prior CABG patients were older (mean age 71 years vs 65 years), more comorbid and less likely to be revascularised than those without CABG (49.8% vs 73.0%). Compared to patients without CABG, at a mean follow-up of 2.1 years, patients with prior CABG had higher all-cause mortality (HR 2.03 (1.80-2.29)), and were more likely to have recurrent myocardial infarction (HR 2.70 (2.40-3.04)), rehospitalisation with congestive cardiac failure (HR 2.36 (2.10-2.66)) and stroke (HR 1.82 (1.41-2.34)). CONCLUSION: In contemporary real-world practice, despite half of the patients with ACS and prior CABG receiving PCI, the outcomes remain poor compared with those without prior CABG.
No takes yet. Share an insight, caveat, or question.
Kerr et al. (2022) conducted a cohort in Acute coronary syndrome (n=26,869). Prior coronary artery bypass grafting (CABG) vs. No prior CABG was evaluated on All-cause mortality (HR 2.03, 95% CI 1.80-2.29, p=<0.001). In patients with acute coronary syndrome undergoing invasive management, a history of prior CABG was associated with a significantly higher risk of all-cause mortality (HR 2.03) compared to no prior CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: